REQUEST A DEMO
Total
USD $0.00
Search more companies

Fortune Pharmaceuticals India Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Fortune Pharmaceuticals India Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Fortune Pharmaceuticals India Private Limited is an unlisted company, incorporated on 21/02/2006. It has its registered office in the State of Jammu and Kashmir, India. Company's corporate identification number (CIN) is U24230JK2006PTC002623 and registration number is 002623. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Export Promotional Industrial Park Kartholi, Bari Brahmana
Jammu; Jammu and Kashmir; Postal Code: 181133

Contact Details: Purchase the Fortune Pharmaceuticals India Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Fortune Pharmaceuticals India Private Limited report to view the information.
Outstanding Shares:
Purchase the Fortune Pharmaceuticals India Private Limited report to view the information.
Registered Capital:
Purchase the Fortune Pharmaceuticals India Private Limited report to view the information.
Incorporation Date:
February 21, 2006
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Fortune Pharmaceuticals India Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
4.93%
Total operating revenue
4.94%
Operating profit (EBIT)
-27.99%
EBITDA
27.61%
Net Profit (Loss) for the Period
-26.42%
Total assets
31.32%
Total equity
52.42%
Operating Profit Margin (ROS)
-0.65%
Net Profit Margin
-0.53%
Return on Equity (ROE)
-10.6%
Debt to Equity Ratio
12.07%
Quick Ratio
-0.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?